ANDA 84631, held by Sandoz. Quinidine Sulfate.
As of Nov 21, 2026, ANDA 84631 (Quinidine Sulfate), held by Sandoz, was first approved by FDA on Nov 24, 1976, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 24, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate200MG · tablet;oral | Quinidine Sulfate | Discontinued |
| Feb 2, 2000 | Supplement 18Manufacturing | Approved | None posted |
| Feb 18, 1999 | Supplement 17Labeling | Approved | None posted |
| Sep 3, 1996 | Supplement 16Labeling | Approved | None posted |
| Feb 28, 1995 | Supplement 14Labeling | Approved | None posted |
| Feb 28, 1995 | Supplement 13Manufacturing | Approved | None posted |
| Oct 29, 1992 | Supplement 15Labeling | Approved | None posted |
| Feb 5, 1988 | Supplement 12Labeling | Approved | None posted |
| Mar 12, 1985 | Supplement 9Manufacturing | Approved | None posted |
| Oct 25, 1983 | Supplement 7Manufacturing | Approved | None posted |
| Oct 25, 1983 | Supplement 6Manufacturing | Approved | None posted |
| Jun 18, 1982 | Supplement 1Manufacturing | Approved | None posted |
| Nov 24, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters